Otto Kollmar1, Michael D Menger, Martin K Schilling. 1. Department of General, Visceral, Vascular and Pediatric Surgery, University of the Saarland, D-66421 Homburg/Saar, Germany. chokol@uniklinik-saarland.de
Abstract
AIM: To study the role of macrophage inflammatory protein (MIP)-2 in liver resection-induced acceleration of tumor growth in a mouse model of hepatic metastasis. METHODS: After a 50% hepatectomy, 1x10(5) CT26.WT cells were implanted into the left liver lobe of syngeneic balb/c mice (PHx). Additional animals were treated with a monoclonal antibody (MAB452) neutralizing MIP-2 (PHx+mAB). Non-resected and non-mAB-treated mice (Con) served as controls. After 7 d, tumor angiogenesis and microcirculation as well as cell proliferation, tumor growth, and CXCR-2 expression were analyzed using intravital fluorescence microscopy, histology, immunohistochemistry, and flow cytometry. RESULTS: Partial hepatectomy increased (P<0.05) the expression of the MIP-2 receptor CXCR-2 on tumor cells when compared with non-resected controls, and markedly accelerated (P<0.05) angiogenesis and metastatic tumor growth. Neutralization of MIP-2 by MAB452 treatment significantly (P<0.05) depressed CXCR-2 expression. Further, the blockade of MIP-2 reduced the angiogenic response (P<0.05) and inhibited tumor growth (P<0.05). Of interest, liver resection-induced hepatocyte proliferation was not effected by anti-MIP-2 treatment. CONCLUSION: MIP-2 significantly contributes to liver resection-induced acceleration of colorectal CT26.WT hepatic metastasis growth.
AIM: To study the role of macrophage inflammatory protein (MIP)-2 in liver resection-induced acceleration of tumor growth in a mouse model of hepatic metastasis. METHODS: After a 50% hepatectomy, 1x10(5) CT26.WT cells were implanted into the left liver lobe of syngeneic balb/c mice (PHx). Additional animals were treated with a monoclonal antibody (MAB452) neutralizing MIP-2 (PHx+mAB). Non-resected and non-mAB-treated mice (Con) served as controls. After 7 d, tumor angiogenesis and microcirculation as well as cell proliferation, tumor growth, and CXCR-2 expression were analyzed using intravital fluorescence microscopy, histology, immunohistochemistry, and flow cytometry. RESULTS: Partial hepatectomy increased (P<0.05) the expression of the MIP-2 receptor CXCR-2 on tumor cells when compared with non-resected controls, and markedly accelerated (P<0.05) angiogenesis and metastatic tumor growth. Neutralization of MIP-2 by MAB452 treatment significantly (P<0.05) depressed CXCR-2 expression. Further, the blockade of MIP-2 reduced the angiogenic response (P<0.05) and inhibited tumor growth (P<0.05). Of interest, liver resection-induced hepatocyte proliferation was not effected by anti-MIP-2 treatment. CONCLUSION:MIP-2 significantly contributes to liver resection-induced acceleration of colorectal CT26.WT hepatic metastasis growth.
Authors: Tom A Drixler; Mathys J Vogten; Ewan D Ritchie; Theo J M V van Vroonhoven; Martijn F B G Gebbink; Emile E Voest; Inne H M Borel Rinkes Journal: Ann Surg Date: 2002-12 Impact factor: 12.969
Authors: Thomas Hehlgans; Benjamin Stoelcker; Peter Stopfer; Peter Müller; Grigore Cernaianu; Markus Guba; Markus Steinbauer; Sergei A Nedospasov; Klaus Pfeffer; Daniela N Männel Journal: Cancer Res Date: 2002-07-15 Impact factor: 12.701
Authors: Keith A Delman; Jonathan S Zager; Joseph J Bennett; Sandeep Malhotra; Michael I Ebright; Priscilla F McAuliffe; Marc W Halterman; Howard J Federoff; Yuman Fong Journal: Ann Surg Date: 2002-09 Impact factor: 12.969
Authors: Maximilian von Heesen; Jochen Schuld; Jens Sperling; Frank Grünhage; Frank Lammert; Sven Richter; Martin K Schilling; Otto Kollmar Journal: Langenbecks Arch Surg Date: 2011-11-17 Impact factor: 3.445
Authors: Kathrin Rupertus; Otto Kollmar; Claudia Scheuer; Bastian Junker; Michael D Menger; Martin K Schilling Journal: Clin Exp Metastasis Date: 2007-01-27 Impact factor: 5.150